1[1]Asimakopoulos G, Smith PL, Ratnatunga CP, et al. Lung injury and acute respiratory distress syndrome after cardiopuhnonary bypass[ J]. Ann Thorac Surg, 1999,68:1107 - 1115.
2[2]McGowan FX, Jr Ikegami M, del Nido PJ, et al. Cardiopulmonary bypass significantly reduces surfactant activity in children [ J ]. Thorac Cardiovasc Surg, 1993, 106:968 - 977.
3[3]Matata BM, Sosnowski AW, Galinanes M. Off - pump bypass graft operation significantly reduces oxidative stress and inflammation[J]. Ann Thorac Surg, 2000,69: 785 - 791.
4[4]Loer SA, Scheeren TW, Tarnow J. How much oxygen docs the human lung consume[ J ] ? Anesthesiology, 1997,86: 532 - 537.
5[5]Quinlan GJ, Mumby S, Lamb NJ, et al. Acute respiratory distress syndrome secondary to cardiopulmonary bypass: do compromised plasma iron-binding anti- oxidant protection and thiol levels influence outcome [ J ] ?Crit Care Med, 2000, 28 : 2271 - 2276.
6[6]Birdi 1, Regragui IA, Izzat MB, et al. Effects of cardiopulmonary bypass temperature on pulmonay gas exchange after coronary artery operations [J].Ann Thorac Surg, 1996,61: 118- 123.
7[7]Ranucci M, Soro G, Frigiola A, et al. Nonnothemic perfusion and lung function after cardiopulmonary bypass: effects in pulmonary risk patients [J]. Peffusion, 1997,12:309 - 315.
8[8]Tonz M, Mihaljevic T, Von Segesser LK, et al. Acute lung injury during cardiopulmonary bypass: are the neutrophils responsible[J]? Chest, 1995,108:1551 - 1556.
9[9]Aouifi A, Piriou V, Blanc P, et al. Effect of cardiopulmonary bypass on serum procalcitonin and C reactive protection concentrations [ J ]. Br J Anesth, 1999,83:602 - 607.
10[10]Hensel M, Volk T, Docke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cantiopulmonary bypass[ J]. Anesthesiol, 1998,89:93 - 104.
